Faculty profile

Mohsen Sadatsafavi

ResearcherMedicine/RespirologyUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Mohsen Sadatsafavi

Researcher

Medicine/Respirology

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
123 publications in the last five years, latest in 2026.
Senior (last) author on 37 recent papers, a sign of leading a research group.
Principal investigator on 6 research grants (6 CIHR), most recently in 2020.
Supervisor on 4 trainee awards (4 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

273

Publications

682

Citations

100

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Chronic Obstructive Pulmonary Disease Health Economics Evidence Synthesis Health Policy Asthma Clinical Prediction Models Electronic Health Records Health Services Research

Latest papers

Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease
Respiratory Medicine · 2026
Development of an asthma policy model for Canada: Lifetime Exposures and Asthma outcomes Projection
PLoS ONE · 2026 · senior author
Reply to Su et al.: Revisiting Risk Estimation in COPD: When Model Outputs Diverge from Clinical Direction.
Annals of the American Thoracic Society · 2026

All 273 publications

Latest funding

Modelling the impact of air quality and climate change in asthma and COPD related hospitalizations
CIHR · 2026 · Supervisor
$9,000
Precision-Driven Policy Modelling: Risk Based Lung Cancer Screening in Chronic Obstructive Pulmonary Disease
CIHR · 2025 · Supervisor
$120,000
Economic evaluation of integrating digital health technologies into routine clinical care for chronic obstructive pulmonary disease
CIHR · 2025 · Supervisor
$120,000

All 19 grants and awards

From the 150 most recent of 273 publications.

Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease

Nalesso G, Ferranti G, Marinescu D-C, Johannson KA, Marcoux V, Fisher JH, Assayag D, Manganas H, Kolb M, Ryerson CJ

Respiratory Medicine2026

DOI: 10.1016/j.rmed.2026.108808

Development of an asthma policy model for Canada: Lifetime Exposures and Asthma outcomes Projection

Lee TY, Petkau J, Johnson KM, Turvey SE, Adibi A, Subbarao P, Hill A, Ewert M, Sadatsafavi M

PLoS ONE2026Senior author

DOI: 10.1371/journal.pone.0348878

Reply to Su et al.: Revisiting Risk Estimation in COPD: When Model Outputs Diverge from Clinical Direction.

Salimian S, Hawkins NM, Sadatsafavi M, Turgeon RD

Annals of the American Thoracic Society2026

DOI: 10.1093/annalsats/aaoag280 PMID: 42696429

Beyond random variation: Monte Carlo analysis and predictability of COPD exacerbations.

Bhatt SP, Bodduluri S, Tlimat A, Nakhmani A, Sadatsafavi M

ERJ open research2026Senior author

DOI: 10.1183/23120541.01516-2025 PMID: 42707515

Nonparametric Assessment of the Calibration of Individualized Treatment Effects.

Sadatsafavi M, Hoogland J, Debray TPA, Petkau J

Statistics in medicine2026First author

DOI: 10.1002/sim.70724 PMID: 42639845

Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.

Hansen S, Tsai MJ, Tran TN, Blakey JD, Emmanuel B, Aaron SD, Habis Y, Perugini V, Altraja A, Katial RK, Perez-de-Llano L, Pfeffer PE, Papadopoulos NG, Townend J, Scelo G, Beastall A, Bulathsinhala L, Busby J, Lindsley AW, Moore WC, Panettieri RA, Canonica GW, Heffler E, Cardini C, Guida G, Porsbjerg CM, Bjerrum AS, Von Bülow A, Hilberg O, Håkansson KEJ, Soendergaard MB, Ulrik CS, Wang E, Wechsler ME, Chapman N, Hoyte FCL, Otsu K, Heaney LG, Jackson DJ, Patel PH, Ryan D, Bergeron C, Abercromby S, Bhutani M, Chapman KR, Côté A, Davis BE, Dorscheid DR, Hoshyari L, Philipenko B, Serajeddini H, Schleich F, Louis R, Kuna P, Cosio BG, Larenas-Linnemann D, Torres-Duque CA, Fernández-Sánchez MJ, Garcia E, Bolívar-Grimaldos F, Jiménez-Maldonado L, Cano-Rosales DJ, Solarte I, Al-Lehebi R, Bulkhi AA, Al-Ahmad M, Iwanaga T, Hozawa S, Matsumoto H, Nagano T, Tajiri T, Aarli BB, Perng DW, Hsiao YH, Fu PK, Sheu CC, Kostikas K, Gaga M, Gogali A, Kallieri M, Loukides S, Makris M, Ntakoula MD, Papaioannou AI, Paraskevopoulos G, Psarros F, Mahboub B, Salameh L, Koh MS, Liew MF, Pang PH, Tan TL, Tay TR, Pitrez PM, Rhee CK, Lugogo N, Mohan A, Fonseca JA, da Silva AA, Loureiro CC, Dos Santos HCAS, Máspero JF, Ardusso LRF, Franchi ME, Sivori M, Stok AM, Yañez A, Christoff G, Popov TA, Mitchell PD, Salvi SS, Costello RW, Denton E, Hew M, Jenkins CR, Langton D, Middleton PG, Peters MJ, Lehtimäki L, Bourdin A, Taillé C, Taube C, Csoma Z, Lúdvíksdóttir D, van Boven JFM, Fingleton J, Bjermer L, Emery H, Lough G, Pleasants RA, Maselli DJ, Ambrose CS, Emmas C, Menzies-Gow AN, Carter V, Eleangovan N, Murray RB, Price CA, Sadatsafavi M, Price DB, ISAR GLEAM Working Group, ISAR GLEAM Working Group, List of ISAR collaborators, List of CHRONICLE collaborators, ISAR GLEAM Working Group, List of ISAR collaborators, List of CHRONICLE collaborators

Journal of asthma and allergy2026

DOI: 10.2147/jaa.s597657 PMID: 42638984

Discriminative performance and clinical utility of chronic obstructive pulmonary disease exacerbation categories for predicting future exacerbations.

Bhatt SP, Adibi A, Bodduluri S, Bowler RP, Burgel PR, Castaldi PJ, Hersh CP, Janson C, Maiorino E, Mullerova H, Nakhmani A, Oelsner EC, Silverman EK, Wilson CG, Sadatsafavi M

American journal of respiratory and critical care medicine2026Senior author

DOI: 10.1093/ajrccm/aamag118 PMID: 42085195

Transportability of Prognostic Markers: Rethinking Common Practices through a Sufficient-Component-Cause Perspective.

Sadatsafavi M, Pereira G, Chen W

Epidemiology (Cambridge, Mass.)2026First author

DOI: 10.1097/ede.0000000000002044 PMID: 42765508

Performance of cardiovascular disease risk prediction tools in chronic obstructive pulmonary disease.

Salimian S, Hawkins NM, Amegadzie JE, Sadatsafavi M, Turgeon RD

Annals of the American Thoracic Society2026

DOI: 10.1093/annalsats/aaoag073 PMID: 41883123

Advancing cardiovascular risk stratification in COPD: methodological gains and remaining gaps.

Samarasinghe Y, Sadatsafavi M

The European respiratory journal2026Senior author

DOI: 10.1183/13993003.00497-2026 PMID: 42492990

Something wrong or missing on this profile? Suggest a correction

Mohsen Sadatsafavi

Research

Latest papers

Latest funding

Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease

Development of an asthma policy model for Canada: Lifetime Exposures and Asthma outcomes Projection

Reply to Su et al.: Revisiting Risk Estimation in COPD: When Model Outputs Diverge from Clinical Direction.

Beyond random variation: Monte Carlo analysis and predictability of COPD exacerbations.

Nonparametric Assessment of the Calibration of Individualized Treatment Effects.

Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.

Discriminative performance and clinical utility of chronic obstructive pulmonary disease exacerbation categories for predicting future exacerbations.

Transportability of Prognostic Markers: Rethinking Common Practices through a Sufficient-Component-Cause Perspective.

Performance of cardiovascular disease risk prediction tools in chronic obstructive pulmonary disease.

Advancing cardiovascular risk stratification in COPD: methodological gains and remaining gaps.

Frequent collaborators

Teresa To

Martin Rainer Kolb

Gerard Cox

Nathan Hambly

Deborah Assayag

Larry Lynd

Stirling Bryan

Carlo Marra

Andrea Gershon

Tetyana Kendzerska

Mahyar Etminan

Jeenat Mehareen

Christopher Carlsten

Stuart Peacock

Stuart Peacock

Tetyana Kendzerska

Hubert Wong

Kednapa Thavorn

Kednapa Thavorn

Mark Harrison

Douglas Manuel

Padmaja Subbarao

Sunita Mulpuru

Diane Lacaille

Zhiwei Gao

Kate Johnson

Gillian Hanley

Samir Gupta

Padmaja Subbarao

Michal Abrahamowicz

Lucie Blais

Teresa Liu-Ambrose

Helen Tremlett

Deborah Marshall

Fawziah Lalji

Mohammed Abdul Malik Farooqi

Kristian Thorlund

Gordon Guyatt

Jeremy Hirota

Paul O'Byrne